Reviewing the Latest in Breast Cancer and Myeloma: Drs Tarantino and Raje
Tucidinostat Plus R-CHOP Improves EFS in DLBCL Expressing MYC and BCL2
Abemaciclib/Fulvestrant Boosts PFS in HR+/HER2– Breast Cancer Post–CDK4/6i Progression
Inavolisib Plus Palbociclib/Fulvestrant Bolsters PFS in HR+/HER2–, PIK3CA-Mutant Breast Cancer